From: Influence of continuous erythropoietin receptor activator (CERA) administration intervals on erythropoietic effect in hemodialysis patients
CERA dosage (μg/4 weeks)
Q2W/1000 (cells/μL)
Q4W/1000 (cells/μL)
p value
50 (N = 25)
40.7 ± 10.0
36.2 ± 9.9
<0.005
100 (N = 13)
41.6 ± 12.5
35.8 ± 7.8
<0.05
150 (N = 6)
44.7 ± 10.8
38.4 ± 7.0
All (N = 44)
41.5 ± 10.7
36.4 ± 8.8
<0.0001